Carmell Therapeutics' Grant

Carmell Therapeutics raised a round of funding on May 19, 2014. Investors include National Institutes of Health.

Carmell Therapeutics is developing biologically-active medical devices manufactured from blood plasma with growth and regenerative factors designed by nature in the right proportions to heal tissues. …

Articles about Carmell Therapeutics' Grant: